Form 4: Core Labs SVP Gresham Vests Performance Shares

Core Laboratories Inc. SVP Gwendolyn Gresham vested 24,952 performance shares and disposed of 19,301 shares for tax purposes following strong company performance.

Summary

• Gwendolyn Gresham, SVP of Core Laboratories Inc., reported transactions related to her equity holdings.
• On December 31, 2025, 24,952 performance shares vested, converting into common stock.
• These shares were originally awarded as restricted performance shares in February 2023.
• The vesting occurred because Core Laboratories Inc. achieved the 68th percentile of return on invested capital among its Bloomberg Peer Group at the end of the performance period on December 31, 2025.
• The performance criteria were satisfied at 116.5% of the target award level.
• Concurrently, 19,301 shares of common stock were disposed of at a price of $16.03 per share, likely to cover tax obligations related to the vesting.
• Following these transactions, Gresham directly beneficially owns 52,527 shares of common stock.

Sentiment

Score: 8

Explanation: The vesting of performance shares at 116.5% of target, driven by the company's 68th percentile ROIC performance, indicates strong operational execution and successful alignment of executive incentives with shareholder value. The disposition of shares is a routine tax event.

Positives

• Core Laboratories Inc. achieved strong performance, finishing in the 68th percentile of return on invested capital among its Bloomberg Peer Group.
• Performance criteria for restricted shares were satisfied at 116.5% of the target award level, indicating overachievement.
• The vesting of 24,952 performance shares for SVP Gwendolyn Gresham demonstrates successful long-term incentive plan execution tied to company performance.

Future Outlook

This filing does not contain specific forward-looking statements or guidance regarding future company performance or strategic initiatives.

Industry Context

This filing reflects a standard executive compensation event tied to performance, common across industries where long-term incentives are used to align management interests with shareholder value creation. The achievement of the 68th percentile in ROIC suggests competitive performance within the oilfield services or energy sector, where Core Laboratories operates.

Comparison to Industry Standards

• Core Laboratories Inc. achieved the 68th percentile of return on invested capital among its Bloomberg Peer Group, indicating above-average performance compared to its industry peers.
• The vesting of performance shares at 116.5% of the target award level suggests that the company's performance exceeded internal targets, which is a positive indicator for executive incentive plan effectiveness.

Stakeholder Impact

• Shareholders: Positive impact due to demonstrated strong company performance (68th percentile ROIC) leading to executive incentive vesting, suggesting effective management.
• Employees: No direct impact mentioned, but strong company performance can generally lead to a more stable and rewarding work environment.

Key Dates

Recommendation

The filing indicates strong past performance leading to executive compensation vesting, which is a positive signal. However, it's a historical transaction report and doesn't provide new forward-looking guidance or significant strategic shifts. While the performance is commendable, a 'hold' recommendation is appropriate as this single filing alone doesn't warrant a 'buy' without further analysis of current valuation, future prospects, and broader market conditions. The disposition of shares for tax purposes is a routine event and not a signal of lack of confidence.

Keywords

Core Laboratories, CLB, Form 4, Insider Transaction, Performance Shares, Stock Vesting, Executive Compensation, Return on Invested Capital, SVP, Gwendolyn Gresham